Literature DB >> 1717940

A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts.

F Hoppe-Seyler1, K Butz, C Rittmüller, M von Knebel Doeberitz.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1717940      PMCID: PMC328819          DOI: 10.1093/nar/19.18.5080

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

Authors:  A R Brasier; J E Tate; J F Habener
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

2.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

3.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

  3 in total
  20 in total

1.  Nuclear and cytosolic calcium are regulated independently.

Authors:  M F Leite; E C Thrower; W Echevarria; P Koulen; K Hirata; A M Bennett; B E Ehrlich; M H Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

2.  Isolation and functional characterization of two distinct sexual-stage-specific promoters of the human malaria parasite Plasmodium falciparum.

Authors:  K J Dechering; A M Kaan; W Mbacham; D F Wirth; W Eling; R N Konings; H G Stunnenberg
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice.

Authors:  Yu Mei; Sundararajah Thevananther
Journal:  Hepatology       Date:  2011-10-11       Impact factor: 17.425

4.  Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway.

Authors:  Andrew Remppis; Florian Bea; Henry Johannes Greten; Annette Buttler; Hongjie Wang; Qianxing Zhou; Michael R Preusch; Ronny Enk; Robert Ehehalt; Hugo Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2010-06-21       Impact factor: 4.711

5.  Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

6.  Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway.

Authors:  Kun-Hung Shen; Shun-Hsing Hung; Li-Te Yin; Chun-Shui Huang; Chang-Hung Chao; Chein-Liang Liu; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-08-20       Impact factor: 3.396

7.  Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells.

Authors:  Jiunn-Min Shieh; Tai-An Chiang; Wen-Teng Chang; Chang-Hung Chao; Yi-Chieh Lee; Guan-Yu Huang; You-Xin Shih; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-09-21       Impact factor: 3.396

8.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.

Authors:  M von Knebel Doeberitz; C Rittmüller; F Aengeneyndt; P Jansen-Dürr; D Spitkovsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.

Authors:  K Butz; F Hoppe-Seyler
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.